The Commercialization and Licensing group supports MD Anderson's mission to eliminate cancer as a health threat by accelerating the entrance of new drugs, diagnostics, devices and therapies into the commercial marketplace.
We accomplish this goal through:
- Prudent investment of Institution resources in patents
- Marketing and licensing MD Anderson ideas and inventions to industry
- The creation of new entities (start-ups)
- A long-term view of licensing income and equity value
Technologies Available for Licensing
The portfolio of technologies available for licensing changes frequently.
Please contact the Office of Technology Commercialization with a brief "wish list" of technologies and disease categories in which you have an interest.
Email our contact at: firstname.lastname@example.org, or call the Office of Technology Commercialization at (713) 745-9602.